Arena Pharma (ARNA) BELVIQ Trends Remain Underwhelming, BMO Capital Notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/31/2026
- Wall St struggles for direction as rate uncertainty offsets Amazon jump
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- KBR names its Mission Technology Solutions spinoff Trinzic
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- Wall Street ends sharply higher, lifted by soaring Microsoft
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Rivian Automotive (RIVN) Tops Q2 EPS by 20c, Tops on Revenue; Delivers 12,194 EVs
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Arena Pharma (ARNA), Eisai Will Present Lorcaserin HCl Data at Two Upcoming Meetings
May 14, 2015 8:02 AM EDTEisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that lorcaserin HCl data will be presented at the following medical meetings:
American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015Lorcaserin for Smoking Cessation Treatment in Cigarette Smokers:... MoreArena Pharma (ARNA) Tops Q1 EPS by 4c
May 11, 2015 4:09 PM EDTArena Pharma (NASDAQ: ARNA) reported Q1 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.56 million.
At March 31, 2015, cash and cash equivalents totaled $241.0 million, including net proceeds of $100.7 million from... More
